BSE filing, NSE: AJMERA. Summary written from the filing by ALFA Finder's alert engine.
Ajmera Realty & Infra India Ltd: key numbers
- Share price
- ₹133.50
- Market cap
- ₹2,627 Cr
- Revenue (annual)
- ₹1,090 Cr
- Net profit (annual)
- ₹149.8 Cr
- P/E (TTM)
- 17.0×Sector 34.0×
- Promoter holding
- 68.56%+0.00% QoQ
- FII holding
- 0.77%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ajmera Realty & Infra India Ltd
All →Ajmera Realty & Infra India Board Meeting Date
Ajmera Realty & Infra intimated BSE and NSE that its Board Meeting is scheduled for 3 November 2026 to consider Q2/H1 FY27 financial results. No decisions or figures are reported in this advance notice.
Ajmera Realty & Infra India Business Update
Ajmera Realty reported Q2FY27 sales value of INR 224 crore and collections of INR 190 crore, reflecting continued operational momentum across its projects.
- Value
- ₹414.0 Cr
Ajmera Realty & Infra India Annual General Meeting
Ajmera Realty & Infra India Ltd. held its 39th Annual General Meeting on 23rd September 2026. All listed agenda items were transacted during the meeting.
Ajmera Realty & Infra India Board Meeting Outcome
Ajmera Realty's board approved NCD/bond issuance up to Rs.500 Crores via private placement. Shareholder approval is required before execution.
- Value
- ₹500.0 Cr
Ajmera Realty & Infra India Board Meeting Date
Ajmera Realty will hold a board meeting on September 10, 2026, to consider and approve a fund-raising proposal via the issuance of Non-Convertible Debentures.
Ajmera Realty & Infra India Acquisition Worth ₹0.01 Cr
Ajmera Realty’s subsidiary acquired a 51% stake in Ajmera MD Realty LLP for Rs. 0.0051 Crore, making it a step-down subsidiary.
- Value
- ₹0.01 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.